The Metabolomics Platform is specialised in developing and applying mass spectrometry-based comprehensive analysis methods of small molecules in complex biological matrices. The platform supports a wide range of cutting-edge metabolomic approaches for several sample types, including

• mammalian cells
• bacteria, yeast
• body fluids (e.g., cerebrospinal fluid, plasma, serum, urine)
• stool
• soft tissues (e.g., brain, liver, lung, heart, kidney)
• others (e.g., dried blood spots)

To address the needs of researchers in this fast-changing field, the Metabolomics Platform is continuously developing new analytical (targeted/untargeted) and tailor-made methods to address cutting-edge biological and biomedical questions. Furthermore, the Metabolomics Platform can provide a comprehensive set of tools for a reliable data analysis based on a statistical evaluation. Moreover, the highly competitive price structure enables Luxembourg researchers to obtain fast, accurate and complete data generation in order to successfully pursue their research goals.